Company Profile

Adaptive Therapeutics Inc (AKA: NanoRX Therapeutics)
Profile last edited on: 11/25/2014      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5820 Nancy Ridge Drive Suite 200
San Diego, CA 92121
   (858) 909-9050
Location: Single
Congr. District: 51
County: San Diego

Public Profile

Adaptive Therapeutics Inc. (ATI) founding technology was developed in Professor M. Reza Ghadiri's laboratory and the company negotiated and secured exclusive worldwide licenses from The Scripps Research Institute (TSRI) to intellectual property rights covering anti-bacterial, anti-fungal, anti-viral, and anti-cancer therapeutic applications of Adaptide peptides

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 1 NIH $100,000
Project Title: Antifungal Activity of Cyclic D,L-alpha Peptides

Key People / Management

  Noubar Afeyan -- President

  Jorge Sanchez-Quesada

Company News

There are no news available.